• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pharma

Magnifying glass with pills on blue
Pharma

Regulatory tracker: CSL Vifor, Amgen, AZ, Daiichi Sankyo

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu , Kevin Dunleavy , Fraiser Kansteiner Sep 1, 2026 2:40pm
Wool heart
Favicon Fierce Biotech

Don't count out Alnylam's next-gen silencer in ATTR-CM: analysts

Sep 1, 2026 1:55pm
video
Why real-world data is becoming a strategic asset in drug development

Why real-world data is becoming a strategic asset in drug development

Brought to you by LabCorp
NVS

Novartis' BTK drug clears ph. 3 in MS sans liver safety signal

Sep 1, 2026 11:10am
Pharma Doesnt Have an AI Problem It Has an Information Problem

Pharma Doesn't Have an AI Problem. It Has an Information Problem.

Brought to you by Intelligencia AI
drug prices biologics drug costs IRA money cash payment co-pay

White House unveils next round of MFN drug pricing deals

Aug 31, 2026 5:10pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings